Search results
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant...
WTNH-TV New Haven· 3 days agoThe ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options. Updated results from the ELECTRA study ...
Property transfers: Sales ranged from $1K to $275K
The Marion Star via Yahoo Finance· 5 days agoByrd and Amy S. Huckaba... Woods Jr. and Desiree Murray to Joshua and Julia Foss; $205,000 1088 Owens Road W., Marion; Dustin R. and Dessiree L. Thomas...
Sennosides Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
WebMD· 5 days agoStomach/abdominal pain or cramping, nausea, diarrhea, or weakness may occur. This medication may cause your urine to turn reddish-brown. This effect is harmless and will disappear when the medication ...
Story from Exparel: Transform recovery from orthopedic surgery with non-opioid pain management
Detroit Free Press· 6 days agoEvery year, over 3.5 million shoulder and knee orthopedic surgeries occur in the United States due...
An All-Star Strategy: How A-Rod Keeps His Gum Disease in Check
The Charleston Gazette· 4 days ago“I realized I needed to prioritize my oral health once I was diagnosed with gum disease, which is a...
Exploring Top Dividend Stocks In Hong Kong May 2024
Simply Wall St. via Yahoo Finance· 4 days agoAs of May 2024, the Hong Kong market has shown resilience with the Hang Seng Index gaining 3.11%, reflecting a positive sentiment among investors despite...
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API...
FOX 59 Indianapolis· 3 days agoEli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the ...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 6 days agoBiocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
Digital Journal· 6 days agoNEW YORK, NY / ACCESSWIRE / May 21, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug development ...
The FMC’s Final Rule on Detention and Demurrage Billing Requirements Takes Effect Despite Pending...
JD Supra· 6 days ago...Shipping Council (“WSC”) filed a petition in the United States Court of Appeals for the District of Columbia Circuit requesting review of the Final Rule on the grounds that: (1) the Final Rule is contrary to the Ocean Shipping Reform Act of 2022 (“OSRA 2022”); (2) the FMC exceeded its authority...
